Abstract
Watch the video or read the poster to learn: The ideal donor characteristics and pool sizes for high quality serum lotsThe different production methods that address specific research needsThe impact of processing methods on reducing lot-to-lot variabilityThe current and future role of human AB serum in cell and gene therapyTrevor Smith is the Product Manager for the Immune Cell Portfolio at BioIVT. He has worked extensively in cell and gene therapy and has published methods of T cell expansion on automated bioreactor systems. He has a deep understanding of how to scale-up therapies through process development, GMP lab design and personnel training. In his current role, he uses this knowledge and his immunology background to help customers commercialize new therapies that will provide better patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
